These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 9695116)

  • 1. The pharmacological role of P-glycoprotein in the intestinal epithelium.
    Van Asperen J; Van Tellingen O; Beijnen JH
    Pharmacol Res; 1998 Jun; 37(6):429-35. PubMed ID: 9695116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of expression/function of intestinal P-glycoprotein under disease states.
    Murakami T; Bodor E; Bodor N
    Expert Opin Drug Metab Toxicol; 2020 Jan; 16(1):59-78. PubMed ID: 31821048
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of P-glycoprotein-mediated intestinal efflux kinetics on oral bioavailability of P-glycoprotein substrates.
    Kwon H; Lionberger RA; Yu LX
    Mol Pharm; 2004; 1(6):455-65. PubMed ID: 16028357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug exsorption from blood into the gastrointestinal tract.
    Arimori K; Nakano M
    Pharm Res; 1998 Mar; 15(3):371-6. PubMed ID: 9563065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative evaluation of the function of small intestinal P-glycoprotein: comparative studies between in situ and in vitro.
    Adachi Y; Suzuki H; Sugiyama Y
    Pharm Res; 2003 Aug; 20(8):1163-9. PubMed ID: 12948013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting drug-drug interactions involving the inhibition of intestinal CYP3A4 and P-glycoprotein.
    Tachibana T; Kato M; Takano J; Sugiyama Y
    Curr Drug Metab; 2010 Nov; 11(9):762-77. PubMed ID: 21189139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies to overcome simultaneous P-glycoprotein mediated efflux and CYP3A4 mediated metabolism of drugs.
    Patel J; Mitra AK
    Pharmacogenomics; 2001 Nov; 2(4):401-15. PubMed ID: 11722289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic role of P-glycoprotein in oral bioavailability and intestinal secretion of grepafloxacin in vivo.
    Yamaguchi H; Yano I; Saito H; Inui K
    J Pharmacol Exp Ther; 2002 Mar; 300(3):1063-9. PubMed ID: 11861816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional interaction of intestinal CYP3A4 and P-glycoprotein.
    Kivistö KT; Niemi M; Fromm MF
    Fundam Clin Pharmacol; 2004 Dec; 18(6):621-6. PubMed ID: 15548232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P-glycoprotein: a defense mechanism limiting oral bioavailability and CNS accumulation of drugs.
    Fromm MF
    Int J Clin Pharmacol Ther; 2000 Feb; 38(2):69-74. PubMed ID: 10706193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active secretion and enterocytic drug metabolism barriers to drug absorption.
    Wacher VJ; Salphati L; Benet LZ
    Adv Drug Deliv Rev; 2001 Mar; 46(1-3):89-102. PubMed ID: 11259835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal drug transporters: in vivo function and clinical importance.
    Kunta JR; Sinko PJ
    Curr Drug Metab; 2004 Feb; 5(1):109-24. PubMed ID: 14965254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of grapefruit juice on intestinal P-glycoprotein: evaluation using digoxin in humans.
    Parker RB; Yates CR; Soberman JE; Laizure SC
    Pharmacotherapy; 2003 Aug; 23(8):979-87. PubMed ID: 12921244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The gut as a barrier to drug absorption: combined role of cytochrome P450 3A and P-glycoprotein.
    Zhang Y; Benet LZ
    Clin Pharmacokinet; 2001; 40(3):159-68. PubMed ID: 11327196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors and dosage formulations affecting the solubility and bioavailability of P-glycoprotein substrate drugs.
    Murakami T; Bodor E; Bodor N
    Expert Opin Drug Metab Toxicol; 2021 May; 17(5):555-580. PubMed ID: 33703995
    [No Abstract]   [Full Text] [Related]  

  • 16. Novel experimental parameters to quantify the modulation of absorptive and secretory transport of compounds by P-glycoprotein in cell culture models of intestinal epithelium.
    Troutman MD; Thakker DR
    Pharm Res; 2003 Aug; 20(8):1210-24. PubMed ID: 12948019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active secretion of drugs from the small intestinal epithelium in rats by P-glycoprotein functioning as an absorption barrier.
    Terao T; Hisanaga E; Sai Y; Tamai I; Tsuji A
    J Pharm Pharmacol; 1996 Oct; 48(10):1083-9. PubMed ID: 8953513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of chronic renal failure on the expression and function of rat intestinal P-glycoprotein in drug excretion.
    Veau C; Leroy C; Banide H; Auchère D; Tardivel S; Farinotti R; Lacour B
    Nephrol Dial Transplant; 2001 Aug; 16(8):1607-14. PubMed ID: 11477162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple pathways are involved in the oral absorption of BMS-262084, a tryptase inhibitor, in rats: role of paracellular transport, binding to trypsin, and P-glycoprotein efflux.
    Kamath AV; Morrison RA; Harper TW; Lan SJ; Marino AM; Chong S
    J Pharm Sci; 2005 May; 94(5):1115-23. PubMed ID: 15793809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transport proteins and intestinal metabolism: P-glycoprotein and cytochrome P4503A.
    Christians U
    Ther Drug Monit; 2004 Apr; 26(2):104-6. PubMed ID: 15228147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.